Evolved By Nature's Peptide Platform Used in FDA-Cleared Prescription Therapy for the Management of Atopic Dermatitis
Source: PRNewswire· August 20, 2026
SynaBot summary
A new prescription skin spray for eczema, New Day™ Skin Spray, has received FDA clearance. This medical device utilizes a unique peptide platform derived from nature, marking a significant advancement in dermatological treatment options.
Key takeaways
- FDA-cleared prescription therapy for eczema launched.
- Employs an advanced peptide platform technology.
- Demonstrates AI's role in medical breakthroughs.
Why it matters
This development shows how AI and advanced biological engineering can create novel therapeutic solutions. For AI users, it highlights the potential for sophisticated AI models to accelerate drug discovery and medical device innovation.
This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
AI Tools
- KNIME Analytics PlatformKNIME Analytics Platform is an open-source platform for data science. It enables visual creation of data pipelines and machine learning workflows. Connect to diverse data sources and integrate various data tools.
- Drift Conversational PlatformDrift combines conversational AI with live chat to enhance sales and customer support. Its chatbots engage visitors, answer questions, and route inquiries, optimizing the buyer experience.
- Kore.ai Experience PlatformKore.ai offers an enterprise-grade platform for building highly intelligent virtual assistants and process automation solutions. It supports conversational AI across multiple channels and languages. The platform focuses on delivering transformative customer and employee experiences.
